(April 11, 2023, 12:29 PM EDT) -- NEW ORLEANS — The Food and Drug Administration and the company that makes the brand-name mifepristone abortion pill on April 10 filed emergency motions asking the Fifth Circuit U.S. Court of Appeals to stay a ruling by a Texas federal district court that itself stays the FDA’s approval of the drug and to, if necessary, stay the case until the movants can seek relief from the U.S. Supreme Court....